Skip to main content
Clinical Trials/ACTRN12617000054314
ACTRN12617000054314
Completed
未知

A Randomized Controlled Trial of Ambulatory Oxygen versus Air via Portable Concentrator in Chronic Interstitial Lung Disease

Dr Yet Hong Khor0 sites30 target enrollmentJanuary 11, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Yet Hong Khor
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2017
End Date
October 23, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Yet Hong Khor

Eligibility Criteria

Inclusion Criteria

  • \* Able to give written informed consent
  • \* Chronic interstitial lung disease of any aetiology
  • \* Able to perform a 6\-minute walk test
  • \* Desaturates to \< 90% on room air during the 6\-minute walk test
  • \* Modified Medical Research Council Dyspnoea Scale greater than or equal to 1
  • \* Participated in pulmonary rehabilitation within the 12 months prior to enrolment or has declined the offer of participation in pulmonary rehabilitation.

Exclusion Criteria

  • \* Current domiciliary or ambulatory oxygen use
  • \* Patients meeting criteria for long term oxygen therapy based on measured arterial partial pressure of oxygen (defined as stable daytime PaO2 less than or equal to 55 mmHg, or stable daytime PaO2 56\-59 mmHg with evidence of hypoxic organ damage (including right heart failure, pulmonary hypertension or polycythaemia)
  • \* Significant communication or locomotor difficulties
  • \* Current smokers
  • \* Patients with concurrent chronic obstructive pulmonary disease (FEV1/FVC \<60% and elevated RV/TLC ratio)
  • \* Unstable disease in the last 4 weeks before screening
  • \* Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials